Stock-Based Compensation - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands |
|
|
12 Months Ended |
|
Sep. 27, 2021 |
Jul. 20, 2021 |
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
Jul. 21, 2021 |
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
| Grants, net of withholding taxes (in shares) |
200,373
|
|
|
|
|
|
| Compensation expense |
|
|
$ 1,063,351
|
$ 553,600
|
$ 20,439
|
|
| Common unit, outstanding (in shares) |
|
|
|
547,466
|
|
|
| Stock price (USD per share) |
|
|
|
|
|
$ 10
|
| Total Class B stock-based compensation expense |
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
| Compensation expense |
|
|
1,058,442
|
$ 553,600
|
20,439
|
|
| RSU and SAR |
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
| Compensation expense |
|
|
$ 2,340
|
|
|
|
| Vesting period |
|
|
4 years
|
|
|
|
| SARs |
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
| Granted stock (in shares) |
|
|
1,935,131
|
|
|
|
| Remaining contractual term |
|
|
9 years 8 months 12 days
|
|
|
|
| Stock price (USD per share) |
|
|
$ 8.30
|
|
|
|
| Common Stock - Class A |
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
| Grants in period to each employee (in shares) |
500
|
|
|
|
|
|
| Granted stock (in shares) |
309,500
|
|
|
|
|
|
| Compensation expense |
$ 2,569
|
|
|
|
|
|
| Stock price (USD per share) |
|
|
|
|
|
$ 10.00
|
| Common Stock - Class B |
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
| Granted stock (in shares) |
|
|
17,690,000
|
62,676,000
|
|
|
| Compensation expense |
|
|
$ 123,449
|
$ 78,398
|
$ 14,831
|
|
| Vesting period |
|
|
8 years
|
|
|
|
| Common unit, outstanding (in shares) |
|
589,465
|
|
|
|
|
| Conversion of Common Units (in shares) |
|
152,822,842
|
|
|
|
|
| Incremental compensation expense |
|
$ 292,580
|
|
|
|
|
| Weighted-average grant date fair value (in dollars per share) |
|
|
$ 2,195.16
|
$ 178.69
|
|
|